Integra Lifesciences Holdings Corp (NAS:IART)
$ 30.8 -0.31 (-1%) Market Cap: 2.43 Bil Enterprise Value: 1.93 Bil PE Ratio: 61.60 PB Ratio: 0.84 GF Score: 77/100

Integra Lifesciences Holdings to Acquire ACell Inc - Conference Call Transcript

Dec 16, 2020 / 02:00PM GMT
Release Date Price: $60.81 (+2.01%)
Operator

Good day, and welcome to the Integra LifeSciences Business Update Call. Today's call is being recorded.

At this time, I'd like to turn the conference over to Mr. Mike Beaulieu. Please go ahead, sir.

Michael Beaulieu
Integra LifeSciences Holdings Corporation - Director of IR

Thank you, Celeste. Good morning, and thank you for joining the Integra LifeSciences Business Update Call. Joining me on the call are Peter Arduini, President and Chief Executive Officer; and Carrie Anderson, Chief Financial Officer.

Earlier today, we issued a press release announcing an agreement to acquire ACell, Inc. The release and corresponding presentation, which we will reference during the call, are available at integralife.com under Investors, Events & Presentations in the file named ACell Acquisition Investor Presentation.

During this morning's call, Pete and Carrie will provide an overview of the acquisition, including a discussion about the complementary nature of the ACell technology and product portfolio with Integra's Tissue Technologies

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot